Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,581.00
(
0.00%
)
US TECH 100
23,476.40
(
-0.19%
)
Dow Jones
46,208.47
(
0.00%
)
Brent Oil
99.62
(
2.92%
)
Bitcoin
70,919.00
(
0.03%
)
News Focus
News Focus
Post# of 257273
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

oc631

Send PM Follow Ignore
Followers 15
Posts 1749
Boards Moderated 0
Alias Born 08/12/2007

oc631

Re: pcrutch post# 140443

Thursday, 04/19/2012 11:57:05 AM

Thursday, April 19, 2012 11:57:05 AM

Post# of 257273

"BMY spokesperson told me this morning that GILD rejected an offer to further develop daclatasvir and GS-7977 in Ph3"





It should come as no surprise that GILD isn't interested in partnering with BMY. IMO the company that will benefit the most from this news is ABT as both companies (GILD/BMY) struggle with the weak links in their respective mid-stage, in-house oral combinations.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today